SCHEMBL9915128

SCHEMBL9915128

CNCc1cn(I)nn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13471584 0.77
SCHEMBL19723359 0.76 GBA1 (0.36)
SCHEMBL23957857 0.76
SCHEMBL18869734 0.73 GBA1 (0.37)
SCHEMBL15628432 0.73 GBA1 (0.40)
SCHEMBL16330524 0.72 NOTUM (0.44)
SCHEMBL21672550 0.72 MAP3K8 (0.36)
SCHEMBL14262407 0.72 CYP19A1 (0.36)
SCHEMBL22509571 0.69 CYP19A1 (0.34)
SCHEMBL16263165 0.69 GBA1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8198419-B2 Glycorandomization and production of novel erythromycin analogs WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2012-06-12 US disclosed
US-20110124850-A1 Glycorandomization and Production of Novel Vancomycin Analogs THORSON JON 2011-05-26 US disclosed